Why the study?
The FDA's CDER aims to ensure drug safety and effectiveness with clear labeling describing benefits and risks to guide use.
Key points are not available for this paper at this time.
Design
Consensus report from regulatory agency
The report outlines the FDA CDER's commitment to ensuring the safety, effectiveness, and appropriate labeling of human drug products.
T he Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) is responsible for ensuring the safety and effectiveness of human drug products.CDER recognizes the value of therapeutic agents and encourages innovation in their development.CDER tries to ensure that approved drugs are accompanied by labeling that describes the benefits and risks of the drugs and provides good directions for use.
No takes yet. Share an insight, caveat, or question.
Hicks et al. (2011) reported a review. The Center for Drug Evaluation and Research (CDER) of the FDA ensures the safety and effectiveness of human drug products and encourages innovation in their development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: